← Back to Clinical Trials
Recruiting NCT07584941

NCT07584941 Effect of Upper-limb Plyometric Training Versus Strength Training for Enhancing Serve Velocity, Strength, and Power in Competitive Tennis Players

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07584941
Status Recruiting
Phase —
Sponsor Ibadat International University, Islamabad
Condition Upper Limb Strength
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2026-05-15
Primary Completion 2026-07-10

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Upper limb Plyometric TrainingConventional Strength Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2026-05-15 with a primary completion date of 2026-07-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the effects of upper-limb plyometric training and traditional strength training on serve velocity, muscular strength, and power in competitive tennis players. Serve velocity is a critical performance factor in tennis, and optimizing upper-limb function is essential for enhancing performance. Participants will be randomly assigned to either a plyometric training group or a strength training group. Both groups will undergo structured training programs over a defined intervention period. Outcome measures, including serve velocity, upper-limb strength, and power, will be assessed at baseline and after the completion of the intervention. The findings of this study will help determine the most effective training approach for improving performance in tennis players and may guide coaches, athletes, and rehabilitation professionals in designing evidence-based training programs.

Eligibility Criteria

Inclusion Criteria: * Age 18-30 years (male tennis players). * Currently training/competing in tennis ≥3 sessions/week. * Minimum of 4 years of systematic tennis training experience * Provide written informed consent. Exclusion Criteria: * Recent musculoskeletal surgery * Upper-limb (shoulder/elbow) or lower-limb injury that limits training in past 6 months. * Participation in structured strength or agility programs outside routine tennis training * Neurological or cardiovascular disorders or other medical condition contraindicating high-intensity exercise

Contact & Investigator

Central Contact

Sadaqat Saleem, MS. Sports Physical Therapy

✉ sadaqatsaleem36@gmail.com

📞 +923489221909

Principal Investigator

Hafsah Gul Khattak, DPT, MS-NMPT

PRINCIPAL INVESTIGATOR

IBADAT INTERNATIONAL UNIVERSITY, ISLAMABAD (IIUI)

Frequently Asked Questions

Who can join the NCT07584941 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 30 Years, studying Upper Limb Strength. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07584941 currently recruiting?

Yes, NCT07584941 is actively recruiting participants. Contact the research team at sadaqatsaleem36@gmail.com for enrollment information.

Where is the NCT07584941 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07584941 clinical trial?

NCT07584941 is sponsored by Ibadat International University, Islamabad. The principal investigator is Hafsah Gul Khattak, DPT, MS-NMPT at IBADAT INTERNATIONAL UNIVERSITY, ISLAMABAD (IIUI). The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology